Skip to main content
. 2023 May;48(3):302–312. doi: 10.30476/IJMS.2022.94615.2598

Table 2.

COVID-19 reinfection rate in Fars province in terms of demographics and underlying diseases

Variable Reinfection P value
Yes No
Overall 2079 (0.97) 211663 (99.03)
Age group (year) Pediatric (0-14) 28 (0.43) 6441 (99.57) <0.001
Young group (15-47) 1610 (1.15) 138650 (98.85)
Middle age (48-63) 288 (0.67) 42623 (99.33)
Elderly (≥64) 153 (0.63) 23949 (99.37)
Sex Men 1201 (1.04) 114117 (98.96) <0.001
Women 878 (0.89) 97546 (99.11)
Admission type Outpatient 1709 (0.9) 188821 (99.1) <0.001
Inpatient 370 (1.59) 22842 (98.41)
Location Urban 1906 (1.02) 185503 (98.98) <0.001
Rural 173 (0.66) 26160 (99.34)
Job Other jobs 1563 (0.79) 195376 (99.21) <0.001
Health care personnel 498 (3.76) 12744 (96.24)
ICU* hospitalization Yes 24 (1.54) 1536 (98.46) 0.007
No 111 (0.84) 13035 (99.16)
BMI** (Kg/m2) Over 40 8 (0.94) 842 (99.06) 0.863
Below 40 1677 (0.89) 187687 (99.11)
Smoking Yes 24 (0.67) 3584 (99.33) 0.153
No 1661 (0.89) 184945 (99.11)
Hypertension Yes 70 (0.61) 11354 (99.39) 0.001
No 1615 (0.9) 177175 (99.1)
Diabetes Yes 67 (0.63) 10591 (99.37) <0.001
No 2012 (0.99) 201072 (99.01)
Cardiovascular Yes 99 (0.98) 10028 (99.02) 0.959
No 1980 (0.97) 201635 (99.03)
HIV*** Yes 4 (2.2) 178 (97.8) 0.514
No 366 (1.59) 22664 (98.41)
Chronic kidney diseases Yes 38 (1.66) 2246 (98.34) 0.001
No 2017 (0.96) 209125 (99.04)
Chronic neurologic or neuromuscular disease Yes 6 (1.52) 389 (98.48) 0.904
No 364 (1.6) 22453 (98.4)
Chronic pulmonary disease Yes 38 (1.23) 3056 (98.77) 0.128
No 2017 (0.96) 208315 (99.04)
Hepatic disease Yes 4 (2.06) 190 (97.94) 0.601
No 366 (1.59) 22652 (98.41)
Respiratory distress syndrome Yes 1 (0.5) 199 (99.5) 0.215
No 369 (1.6) 22643 (98.4)
Mild pneumonia Yes 3 (0.61) 488 (99.39) 0.079
No 367 (1.62) 22354 (98.38)
Severe pneumonia Yes 7 (0.77) 905 (99.23) 0.042
No 363 (1.63) 21937 (98.37)
Malignancy Yes 20 (2.7) 720 (97.3) <0.001
No 2059 (0.97) 210943 (99.03)

*ICU: Intensive Care Unit; **BMI: Body Mass Index; ***HIV: Human Immunodeficiency Virus; +Pearson Chi square was used for data analysis.